Terikalant

DB20720ExperimentalSmall molecule

Terikalant is a small molecule drug. The usage of the INN stem '-kalant' in the name indicates that Terikalant is a potassium channel blocker. Terikalant has a monoisotopic molecular weight...

Mechanism: Pharmacologically active on Voltage-gated inwardly rectifying potassium channel KCNH2
Curator reviewed
Formula / weight: C₂₄H₃₁NO₃ · 381.516 g/mol (avg)
Code names: RP-58866

Resolves to

Compound

UNIIG8ZMP77RGJCAS121277-96-1ChEMBLCHEMBL96153ChEBI177845PubChem65941

Structure

InChIKeyUIZPEXQHMIZQPQ-IBGZPJMESA-NSMILESCOC1=C(OC)C=C(C=C1)C1CCN(CC[C@H]2CCOC3=CC=CC=C23)CC1

Targets

Q12809KCNH2Q9UK17KCND3P63252KCNJ2

What you can answer from here — as of September 23, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

7+ReferencesStructured and connected to the statements they support

Which drugs share a target with Terikalant, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account